新型冠狀病毒,你真的了解嗎?
日期:2020-02-12 12:12:08
2020年1月30日晚,世界衛(wèi)生組織(WHO)宣布,新型冠狀病毒(SARS-CoV-2)疫情將構成國際關注的突發(fā)公共事件(PHEIC)。這次爆發(fā)的新型冠狀病毒疫情之所以會被列為國際關注的公共衛(wèi)生緊急事件,主要是因為中國內部肺炎感染者數(shù)量在持續(xù)增加,同時,目前已有多個國家出現(xiàn)肺炎疫情,而且確診人數(shù)也有所增加。這一聲明的發(fā)出意味著,與SARS-CoV-2疫情(COVID-19)疫情的搏斗不在僅僅是中國公民的戰(zhàn)爭,更是全球人民的戰(zhàn)斗。那么新型冠狀病毒究竟是什么?怎樣傳播?什么來源?及怎么治療?這些都是我們需要了解的。在了解什么是新型冠狀病毒之前,我們先了解下什么是冠狀病毒。
什么是冠狀病毒?
冠狀病毒屬于套式病毒目、冠狀病毒科、冠狀病毒屬,是一類具有囊膜、基因組為線性單股正鏈的RNA病毒,是自然界廣泛存在的一大類病毒。它不僅是普通感冒的主要病原體之一,更是幾次嚴重疫情的罪魁禍首。2003年肆虐的嚴重急性呼吸綜合征冠狀病毒,以及前幾年影響沙特阿拉伯、韓國等地的中東呼吸綜合征冠狀病毒,在分類上都是冠狀病毒科冠狀病毒屬中的病毒。如Figure 1所示,冠狀病毒呈球形,膜上有冠狀突起,直徑為75-160 nm,病毒基因組為連續(xù)的線性單鏈RNA,分子量通常為(5.5-6.1)x106。

Figure 1. The Typical Structure of Coronavirus
冠狀病毒基因組依次編碼刺突蛋白(S)、包膜蛋白、膜蛋白和核蛋白。其中,刺突蛋白是冠狀病毒最重要的表面膜蛋白。
什么是新型冠狀病毒?
新型冠狀病毒是2019年在人體中發(fā)現(xiàn)的冠狀病毒新毒株,起源于武漢,并于2020年1月12日被世界衛(wèi)生組織命名為SARS-CoV-2。它與2003年的SARS冠狀病毒(SARS CoV)均屬于冠狀病毒的β屬。SARS-CoV-2與2003年"非典"SARS CoV比對,有約70%序列相似性,與MERS CoV有40%的序列相似性。
華美生物密切關注SARS-CoV-2的發(fā)展趨勢,獲取病毒基因序列后,我司迅速開發(fā)生產(chǎn)了SARS-CoV-2相關蛋白和抗體產(chǎn)品。產(chǎn)品涵蓋了大腸桿菌、酵母、桿狀病毒和哺乳動物細胞來源的Spike蛋白(S)和N蛋白(N),以滿足科研、檢測和制備SARS-CoV-2抗體需求。
SARS-CoV-2是如何傳播?
相關研究表明,新型冠狀病毒可通過與眼、口和鼻粘膜中的ACE2相互作用進入人體。目前該病毒正在中國許多地方及其他國家中人與人之間傳播。 1月30日,疾病控制與預防中心(CDC)確定了美國首例人際傳播病例。目前SARS-CoV-2可能傳播的途徑包括:
- 呼吸道飛沫傳播:是新型冠狀病毒主要的傳播途徑,同時也可以通過接觸傳播。手觸摸的物品被含病毒的飛沫污染,病毒可能會經(jīng)手進入口腔、鼻腔、眼睛等粘膜;
- 空氣傳播:病毒攜帶者或感染者的噴嚏和咳嗽;
- 消化系統(tǒng):也就是常說的糞口傳播,部分感染者的糞便中已發(fā)現(xiàn)病毒核酸。
感染SARS-CoV-2后癥狀有哪些?
如Figure 2所示,感染新冠狀病毒后的主要癥狀包括:
- 以發(fā)熱、乏力和干咳為主要表現(xiàn);
- 鼻塞、流涕等上呼吸道癥狀少見;
- 約半數(shù)患者多在一周后出現(xiàn)呼吸困難,嚴重者快速進展為急性呼吸窘迫綜合癥、膿毒癥休克、難以糾正的代謝性酸中毒和凝血功能障礙。
值得注意的是重癥、危重癥患者病理過程中可為中低熱,甚至無明顯發(fā)熱,部分患者起病癥狀輕微,可無發(fā)熱,多在一周后恢復,多數(shù)患者預后良好,少數(shù)患者病情危重,甚至死亡。

Figure 2. The Sympotoms of SARS-CoV-2
SARS-CoV-2來源于何處?
目前,SARS-CoV-2的來源尚不清楚。有專家猜測,這次可能仍然和其他冠狀病毒一樣均來源于野生動物。冠狀病毒通常來源于動物,如駱駝、小鳥和蝙蝠,通常不傳染給人類。但是有時候,冠狀病毒會發(fā)生突變,然后從動物傳播給人類,進而發(fā)展成人傳人,比如2003年SARS流行病。中國國家衛(wèi)生委員會證實,已有15名醫(yī)護人員被感染,表明該病毒可以在人與人之間傳播。
讀到這里,您可能會感到困惑,我應該擔心寵物(例如狗和貓)攜帶SARS-CoV-2嗎?這個目前并沒有證據(jù)顯示貓狗等寵物會感染、傳播新型冠狀病毒。但從衛(wèi)生角度考慮,與寵物接觸后,應用肥皂和水洗手。
如何防止SARS-CoV-2感染?
根據(jù)中疾控和世界衛(wèi)生組織各方專家的觀點,公眾預防應注意以下四個方面:
一是勤洗手。包括在制備食品之前、期間和之后;咳嗽或打噴嚏后;照護病人時;飯前便后;手臟時;在處理動物或動物排泄物后,立刻用肥皂、含有酒精的洗手液和清水洗手。
二是主動防護。在自己咳嗽或打噴嚏時,應用紙巾或袖口或屈肘將口鼻完全遮住,并將用過的紙巾立刻扔進封閉式垃圾箱內,并洗手。易感人群應盡量避免去人群密集的公共場所,可佩戴口罩減少接觸病原風險。避免在未加防護情況下與病人密切接觸,避免觸摸其眼、口、鼻。同時注意保持家庭和工作場所開窗通風,環(huán)境清潔。
三是避免密切接觸。盡量避免在未加防護情況下與養(yǎng)殖或野生動物近距離接觸;避免與生病的動物和變質的肉接觸;避免與生鮮市場里的流浪動物、垃圾廢水接觸。
四是良好安全飲食習慣。將肉和蛋類徹底煮熟食用,處理生食和熟食之間要洗手,切菜板及刀具要分開。
關于SARS-CoV-2感染后的治療,目前尚無特定治療方法,大多數(shù)人會自行康復。所以,治療主要是用藥減輕癥狀,多休息。加濕器或熱水淋浴可以幫助緩解喉嚨痛和咳嗽。如果病情較輕,則應多喝水并休息。
雖然目前還沒有針對新冠狀病毒的疫苗,但從美國國立衛(wèi)生研究院的研究人員處得到證實,疫苗正處于開發(fā)的初期階段。計劃在未來三個月內啟動疫苗的1期臨床試驗。此外,研究人員還致力于收集病毒樣本,旨在設計一種療法來檢測患者的免疫細胞和破壞病毒。
SARS-CoV-2 蛋白產(chǎn)品
Target Name | Product Name | Code | Species | Source | Tag Info |
E & M | Recombinant Severe acute respiratory syndrome coronavirus 2 Envelope small membrane protein & Membrane protein(E & M),partial | CSB-EP3402GND | SARS-CoV-2 | E.coli | N-terminal 6xHis-SUMO-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N) | CSB-EP3325GMY | SARS-CoV-2 | E.coli | N-terminal 6xHis-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N) | CSB-YP3325GMY | SARS-CoV-2 | Yeast | N-terminal 6xHis-PDI-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N) | CSB-MP3325GMY | SARS-CoV-2 | Mammalian cell | Tag-Free |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N) | CSB-YP3325GMYa4 | SARS-CoV-2 | Yeast | N-terminal 6xHis-sumostar-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N),partial | CSB-EP3325GMY1 | SARS-CoV-2 | E.coli | C-terminal 10xHis-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N),Biotinylated | CSB-EP3325GMY-B | SARS-CoV-2 | E.coli | N-terminal MBP-tagged and C-terminal 6xHis-Avi-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N)(D3L,R203K,G204R,S235F) (Active) | CSB-EP3325GMY(M1) | SARS-CoV-2 | E.coli | N-terminal 6xHis-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N)(T205I) (Active) | CSB-EP3325GMY(M2) | SARS-CoV-2 | E.coli | N-terminal 6xHis-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N)(P80R) (Active) | CSB-EP3325GMY(M3) | SARS-CoV-2 | E.coli | N-terminal 6xHis-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N)(P13L) (Active) | CSB-EP3325GMY(M4) | SARS-CoV-2 | E.coli | N-terminal 6xHis-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N)(D103Y) (Active) | CSB-EP3325GMY(M5) | SARS-CoV-2 | E.coli | N-terminal 6xHis-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N)(S202N) (Active) | CSB-EP3325GMY(M8) | SARS-CoV-2 | E.coli | N-terminal 6xHis-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N)(L230F) (Active) | CSB-EP3325GMY(M9) | SARS-CoV-2 | E.coli | N-terminal 6xHis-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N)(I292T) (Active) | CSB-EP3325GMY(M10) | SARS-CoV-2 | E.coli | N-terminal 6xHis-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N)(Q384H) (Active) | CSB-EP3325GMY(M11) | SARS-CoV-2 | E.coli | N-terminal 6xHis-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N)(R203K,G204R) (Active) | CSB-EP3325GMY(M12) | SARS-CoV-2 | E.coli | N-terminal 6xHis-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N)(R203M,D377Y) (Active) | CSB-EP3325GMY(M13) | SARS-CoV-2 | E.coli | N-terminal 6xHis-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein(N)(D63G,R203M,D377Y) (Active) | CSB-EP3325GMY(M14) | SARS-CoV-2 | E.coli | N-terminal 6xHis-tagged |
ns8 | Recombinant Human Novel Coronavirus Non-structural protein 8(ns8) | CSB-EP3366GND | SARS-CoV-2 | E.coli | N-terminal 6xHis-tagged |
NSP3 | Recombinant Severe acute respiratory syndrome coronavirus 2 Non-structural protein 3(nsp3),partial | CSB-EP3398GND | SARS-CoV-2 | E.coli | N-terminal 10xHis-tagged |
NSP5 | Recombinant Severe acute respiratory syndrome coronavirus 2 3C-like proteinase(NSP5) | CSB-EP3389GND | SARS-CoV-2 | E.coli | N-terminal 10xHis-tagged |
Nsp9 | Recombinant Severe acute respiratory syndrome coronavirus 2 Non-structural protein 9(nsp9) | CSB-MP3388GND | SARS-CoV-2 | Mammalian cell | C-terminal hFC-Flag-tagged |
Nsp9 | Recombinant Severe acute respiratory syndrome coronavirus 2 Non-structural protein 9(nsp9) | CSB-EP3388GND | SARS-CoV-2 | E.coli | C-terminal 10xHis-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial | CSB-YP3324GMY2 | SARS-CoV-2 | Yeast | N-terminal 6xHis-PDI-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial | CSB-MP3324GMY1 | SARS-CoV-2 | Mammalian cell | C-terminal 6xHis-mFc-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial | CSB-MP3324GMY1b1 | SARS-CoV-2 | Mammalian cell | N-terminal 10xHis-tagged and C-terminal Myc-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial | CSB-YP3324GMY1 | SARS-CoV-2 | Yeast | N-terminal 6xHis-sumostar-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S) (K417N),partial | CSB-MP3324GMY1(M7) | SARS-CoV-2 | Mammalian cell | C-terminal 10xHis-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S) (K417N),partial | CSB-MP3324GMY1(M7)h8 | SARS-CoV-2 | Mammalian cell | C-terminal mFC-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S) (E484K),partial | CSB-MP3324GMY1(M8) | SARS-CoV-2 | Mammalian cell | C-terminal 10xHis-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S) (E484K),partial | CSB-MP3324GMY1(M8)h8 | SARS-CoV-2 | Mammalian cell | C-terminal mFC-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S) (V367F), partial | CSB-MP3324GMY1(M1) | SARS-CoV-2 | Mammalian cell | C-terminal 10xHis-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S) (W436R), partial | CSB-MP3324GMY1(M2) | SARS-CoV-2 | Mammalian cell | C-terminal 10xHis-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S) (G476S), partial | CSB-MP3324GMY1(M4) | SARS-CoV-2 | Mammalian cell | C-terminal 10xHis-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S) (N501Y), partial | CSB-MP3324GMY1(M6) | SARS-CoV-2 | Mammalian cell | C-terminal 10xHis-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S) (N501Y),partial (Active) | CSB-MP3324GMY1(M6)k2 | SARS-CoV-2 | Mammalian cell | C-terminal 6xHis-mFC-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S) (V483A), partial | CSB-MP3324GMY1(M5) | SARS-CoV-2 | Mammalian cell | C-terminal 10xHis-tagged |
S (RBD) | Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial,Biotinylated | CSB-MP3324GMY1-B | SARS-CoV-2 | Mammalian cell | C-terminal mFc-Avi-tagged |
S (S1) | Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial | CSB-YP3324GMYa4 | SARS-CoV-2 | Yeast | N-terminal 6xHis-sumostar-tagged |
S (S1) | Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial | CSB-MP3324GMY | SARS-CoV-2 | Mammalian cell | N-terminal 10xHis-tagged and C-terminal Flag-tagged |
S (S1) | Recombinant Human Novel Coronavirus Spike glycoprotein(S) (D614G), partial | CSB-MP3324GMY(M1) | SARS-CoV-2 | Mammalian cell | C-terminal 10xHis-tagged |
S (S1) | Recombinant Human Novel Coronavirus Spike glycoprotein(S)(N501Y,P681H), partial | CSB-MP3324GMY(M2) | SARS-CoV-2 | Mammalian cell | C-terminal 10xHis-tagged |
SARS-CoV-2 抗體產(chǎn)品
Product Name | Code | Reactivity Species | Tested Applications |
N Antibody | CSB-RA33255A0GMY | SARS-CoV-2 | ELISA, GICA |
N Antibody | CSB-RA33255A1GMY | SARS-CoV-2 | ELISA, WB, GICA |
N Antibody | CSB-RA33255A2GMY | SARS-CoV-2 | ELISA |
N Antibody, Biotin conjugated | CSB-RA33255D1GMY | SARS-CoV-2 | ELISA |
N Antibody, FITC conjugated | CSB-RA33255C1GMY | SARS-CoV-2 | ELISA |
N Antibody, HRP conjugated | CSB-RA33255B1GMY | SARS-CoV-2 | ELISA |
S Antibody | CSB-RA33245A0GMY | SARS-CoV-2 | ELISA, GICA |
S Antibody | CSB-RA33245A1GMY | SARS-CoV-2 | ELISA, GICA, Neutralising |
S Antibody, Biotin conjugated | CSB-RA33245D1GMY | SARS-CoV-2 | ELISA |
S Antibody, FITC conjugated | CSB-RA33245C1GMY | SARS-CoV-2 | ELISA |
S Antibody, HRP conjugated | CSB-RA33245B1GMY | SARS-CoV-2 | ELISA |
SARS-CoV-2 RBD Nanobody | CSB-RA33245A2GMY | SARS-CoV-2 | ELISA, GICA, Neutralising |
SARS-CoV-2 RBD Nanobody, Biotin conjugated | CSB-RA33245D2GMY | SARS-CoV-2 | ELISA |
SARS-CoV-2 RBD Nanobody, FITC conjugated | CSB-RA33245C2GMY | SARS-CoV-2 | ELISA |
SARS-CoV-2 RBD Nanobody, HRP conjugated | CSB-RA33245B2GMY | SARS-CoV-2 | ELISA |
SARS-CoV-2 Spike RBD Antibody Pair 1 | CSB-EAP33245 | SARS-CoV-2 | S-ELISA |
SARS-CoV-2 N Antibody Pair 1 | CSB-EAP33255A1 | SARS-CoV-2 | S-ELISA |
SARS-CoV-2 N Antibody Pair 2 | CSB-EAP33255A2 | SARS-CoV-2 | S-ELISA |
SARS-CoV-2 N Antibody Pair 3 | CSB-EAP33255A3 | SARS-CoV-2 | S-ELISA |
SARS-CoV-2 N Antibody Pair 4 | CSB-EAP33255A4 | SARS-CoV-2 | S-ELISA |
SARS-CoV-2 免疫抗體產(chǎn)品
Product Name | Code | Tested Applications | Raised in |
S Monoclonal Antibody | CSB-MA33245A0m | GICA | Mouse |
S Monoclonal Antibody | CSB-MA33245A1m | GICA | Mouse |
S Monoclonal Antibody | CSB-MA33245A2m | GICA | Mouse |
S Antibody | CSB-PA33245YA01GMY | GICA | Rabbit |
S Antibody | CSB-PA33245YA11GMY | GICA | Rabbit |
N Antibody | CSB-PA33254A0Rb | GICA | Rabbit |
N Antibody | CSB-MA33255A0m | GICA | Mouse |
N Antibody | CSB-MA33255A1m | GICA | Mouse |
N Antibody | CSB-MA33255A2m | GICA | Mouse |
SARS-CoV-2 試劑盒產(chǎn)品
Product Name | Code | Sample Types | Assay Principle |
SARS-CoV-2 N ELISA Kit | CSB-EL33251 | serum, plasma, swabs | Quantitative |
Human SARS-CoV-2 S RBD Ab (IgG) ELISA Kit | CSB-EL33241HU | serum, plasma | Qualitative |
Human SARS-CoV-2 S RBD Ab (IgM) ELISA Kit | CSB-EL33242HU | serum, plasma | Qualitative |
Human SARS-CoV-2 Neutralizing Antibody ELISA Kit | CSB-EL33243HU | serum, plasma | Qualitative |
Human SARS-CoV-2 N Ab (IgG) ELISA Kit | CSB-EL3325HU | serum, plasma | Qualitative |
Human SARS-CoV-2 N/S1 Ab (IgG) ELISA Kit | CSB-EL3326HU | serum, plasma | Qualitative |
SARS-CoV-2 S1 RBD ELISA Kit | CSB-EL33244 | serum, plasma, swabs | Quantitative |
冠狀病毒相關產(chǎn)品
Target Name | Product Name | Code | Species | Source | Tag Info |
HE | Recombinant Bovine coronavirus Hemagglutinin-esterase(HE) | CSB-YP323648BJK | BCoV | Yeast | N-terminal 6xHis-tagged |
N | Recombinant Bovine coronavirus Nucleoprotein(N) | CSB-EP320768BJK | BCoV | E.coli | N-terminal 6xHis-tagged |
Orf1ab | Recombinant Middle East respiratory syndrome-related coronavirus Orf1ab, partial | CSB-EP2883GJE | MERS-CoV | E.coli | Tag-Free |
S | Recombinant Human coronavirus OC43 Spike glycoprotein(S), partial | CSB-EP336163HIY | HCoV-OC43 | E.coli | N-terminal 6xHis-SUMO-tagged |
S | Recombinant Human coronavirus OC43 Spike glycoprotein(S), partial | CSB-YP336163HIY | HCoV-OC43 | Yeast | N-terminal 6xHis-tagged |
S | Recombinant Bovine coronavirus Spike glycoprotein(S), partial | CSB-EP333052BJO | BCoV | E.coli | N-terminal 6xHis-tagged |
S | Recombinant Bovine coronavirus Spike glycoprotein(S), partial | CSB-EP322803BJK | BCoV | E.coli | N-terminal 10xHis-tagged |
SARS-COV-RBD | Recombinant Human SARS coronavirus Spike glycoprotein(S) ,partial | CSB-MP348663HQE | SARS-CoV | Mammalian cell | N-terminal 10xHis-tagged and C-terminal Myc-tagged |
Product Name | Code | Species Reactivity | Tested Applications |
S Antibody | CSB-PA333052LA01BJO | Bovine coronavirus | ELISA |
S Antibody | CSB-PA322803LA01BJK | Bovine coronavirus | ELISA, WB |
S Antibody | CSB-PA336163EA01HIY | Human coronavirus OC43 | ELISA |
冠狀病毒與宿主互作靶點產(chǎn)品
Target Name | Product Name | Code | Species | Source | Tag Info |
AXL | Recombinant Human Tyrosine-protein kinase receptor UFO(AXL),partial | CSB-MP326981HU | Human | Mammalian cell | C-terminal 10xHis-tagged |
AXL | Recombinant Human Tyrosine-protein kinase receptor UFO(AXL),partial | CSB-MP326981HUd9 | Human | Mammalian cell | C-terminal hFC-tagged |
ACE2 | Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial(Active) | CSB-AP005671HU | Human | Mammalian cell | C-terminal 6xHis-tagged |
ACE2 | Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial | CSB-MP866317HU | Human | Mammalian cell | C-terminal hFc-tagged |
ACE2 | Recombinant Human Angiotensin-converting enzyme 2(ACE2),partial,Biotinylated (Active) | CSB-MP866317HU-B | Human | Mammalian cell | C-terminal mFc-Avi-tagged |
CD147 | Recombinant Human Basigin(BSG),partial | CSB-RP117574h | Human | E.coli | N-terminal 6xHis-tagged |
CD147 | Recombinant Human Basigin(BSG),partial | CSB-MP002831HU | Human | Mammalian cell | C-terminal FC-tagged |
CD147 | Recombinant Human Basigin(BSG),partial | CSB-MP002831HUf3 | Human | Mammalian cell | C-terminal 6xHis-Myc-tagged |
CTSB | Recombinant Human Cathepsin B(CTSB),partial (Active) | CSB-AP005381HU | Human | Mammalian cell | C-terminal 6xHis-tagged |
CTSB | Recombinant Human Cathepsin B(CTSB),partial | CSB-EP006185HU1 | Human | E.coli | N-terminal GST-tagged |
DPP4 | Recombinant Human Dipeptidyl peptidase 4(DPP4) | CSB-CF007139HU | Human | in vitro E.coli expression system | N-terminal 10xHis-tagged |
NUP98 | Recombinant Human Nuclear pore complex protein Nup98-Nup96(NUP98) ,partial | CSB-MP016209HU | Human | Mammalian cell | C-terminal hFC-tagged |
TMPRSS2 | Recombinant Human Transmembrane protease serine 2(TMPRSS2),partial | CSB-EP023924HU | Human | E.coli | N-terminal 6xHis-tagged |
TMPRSS2 | Recombinant Human Transmembrane protease serine 2(TMPRSS2),partial,Biotinylated | CSB-EP023924HU-B | Human | E.coli | N-terminal MBP-tagged and C-terminal 6xHis-Avi-tagged |
TMPRSS2 | Recombinant Human Transmembrane protease serine 2(TMPRSS2),partial | CSB-YP023924HU | Human | Yeast | N-terminal 6xHis-tagged |
TMPRSS2 | Recombinant Human Transmembrane protease serine 2(TMPRSS2),partial | CSB-MP023924HU | Human | Mammalian cell | N-terminal 10xHis-tagged and C-terminal Myc-tagged |
Product Name | Code | Species Reactivity | Tested Applications |
ACE2 Antibody | CSB-PA866317LA01HU | Human | ELISA, IHC, IF |
ACE2 Antibody | CSB-PA001150GA01HU | Human, Mouse, Rat | ELISA,WB |
APN Antibody | CSB-PA001827LA01HU | Human, Mouse | ELISA, WB, IHC, IF |
APN Antibody | CSB-PA001827GA01HU | Human,Mouse,Rat | ELISA,WB |
CD147 antibody | CSB-PA11759A0Rb | Human | ELISA, WB, IHC |
CTSB Antibody | CSB-PA06974A0Rb | Human, Mouse | ELISA, WB, IHC, IF |
DPP4 Antibody | CSB-PA06229A0Rb | Human, Rat | ELISA, WB, IHC, IF |
DPP4 Antibody | CSB-PA007139GA01HU | Human,Mouse,Rat | ELISA,WB,IHC |
TMPRSS2 Antibody | CSB-PA971239 | Human | ELISA,WB |
Product Name | Code | Sample Types | Detection Range |
Human ACE2 ELISA Kit | CSB-E04489h | serum, plasma, cell culture supernates | 0.156 ng/mL-10 ng/mL |
Human APN ELISA kit | CSB-EL001827HU | serum, plasma, tissue homogenates | 31.25 pg/mL-2000 pg/mL |
Human CD147 ELISA Kit | CSB-E12994h | serum, plasma | 12.5 pg/mL-800 pg/mL |
Human CTSB ELISA kit | CSB-E13450h | serum, plasma, tissue homogenates | 0.312 ng/mL-20 ng/mL |
上一篇: 重磅新品!華美CUSABIO2019-nCoVN蛋白現(xiàn)貨供應!
下一篇: 細胞因子風暴